No images? Click here
HealthPlatform.News(letter)
November 10, 2025
In this week’s edition of health news across the states: Hospital cleanliness under scrutiny after Colorado hospital suspends operations, Amgen sues Colorado drug affordability board over price fixing, Momentum grows to modernize menopause care as FDA weighs new guidance
Plus: Gorman, Independence Institute: Stop spending Medicaid money on ineffective programs
A major hospital in Colorado suspended all non-emergency surgical operations for an entire week in July amid a state health inspection due to concerns about the cleanliness of surgical equipment.
For the second time, pharmaceutical company Amgen has filed suit against the Colorado Prescription Drug Affordability Review Board (PDAB) for capping the price of its autoimmune drug, Enbrel. The cap is supposed to take effect in 2027 and would limit the price of the drug to $600 per 50mg weekly dose.
The Food and Drug Administration (FDA) may soon make changes to what is known as the “black box warning” on hormone replacement therapy (HRT) for women in menopause.
Limiting Medicaid enrollment and payments to legally eligible recipients is a good first step towards ensuring the program has enough money to fund treatment for the sick and disabled who cannot live without it. But spending for patients can also be increased by canceling Medicaid services that divert scarce public funds into programs of negligible value to patients.
Support HealthPlatform.News
by contributing to our nonprofit news operation.
Did someone forward this to you?
